特發性肺泡蛋白沉積癥治療進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

白久武 , 徐金富 ,  李惠萍

同濟大學附屬上海市肺科醫院呼吸科(上海 200433);

Corresponding?author：

李惠萍, Email: liw2013@126.com

Keywords：

DOI：

10.7507/1671-6205.2015080

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 白久武, 徐金富, 李惠萍. 特發性肺泡蛋白沉積癥治療進展. Chinese Journal of Respiratory and Critical Care Medicine, 2015, 14(3): 321-324. doi: 10.7507/1671-6205.2015080 Copy

1.	?Rosen SG,Castleman B,Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med,1958,58:1123-1142.
2.	Patel SM,Sekiguchi H,Reynolds JP. Pulmonary alveolar proteinosis. Can Respir J,2012,19:243-245.
3.	Shah PL,Hansell D,Lawson PR,et al. Pulmonary alveolar proteinosis:clinical aspects and current concepts on pathogenesis. Thorax,2000,55:67-77.
4.	Carey B,Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol,2010,135:223-235.
5.	Khan A,Agarwal R,Aggarwal AN. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis:a meta-analysis of observational studies. Chest,2012,141:1273-1283.
6.	Kavuru MS,Malur A,Marshall I,et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J,2011,38:1361-1367.
7.	Luisetti M,Rodi G,Perotti C,et al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J,2009,33:1220-1222.
8.	Verhasselt-Crinquette M,Franquet-Ansart H,Rakza T,et al. Congenital pulmonary alveolar proteinosis related to a surfactant protein B deficiency:report of two cases. Ann Pathol,2009,29:481-484.
9.	Griese M,Ripper J,Sibbersen A,et al. Long-term follow-up and treatment of congenital alveolar proteinosis. BMC Pediatr,2011,11:72.
10.	Dranoff G,Crawford AD,Sadelain M,et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science,1994,264:713-716.
11.	Stanley E,Lieschke GJ,Grail D,et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA,1994,91:5592-5596.
12.	Shibata Y,Berclaz PY,Chroneos ZC,et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity,2001,15:557-567.
13.	Sakagami T,Uchida K,Suzuki T,et al. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med,2009,361:2679-2681.
14.	Uchida K,Nakata K,Trapnell BC,et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colonystimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood,2004,103:1089-1098.
15.	Sakagami T,Beck D,Uchida K,et al. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med,2010,182:49-61.
16.	Ben-Dov I,Segel MJ. Autoimmune pulmonary alveolar proteinosis:clinical course and diagnostic criteria. Autoimmun Rev,2014,13:513-517.
17.	Inoue Y,Trapnell BC,Tazawa R,et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med,2008,177:752-762.
18.	Bonella F,Bauer PC,Griese M,et al. Pulmonary alveolar proteinosis:new insights from a single-center cohort of 70 patients. Respir Med,2011,105:1908-1916.
19.	Campo I,Mariani F,Rodi G,et al. Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis,2013,8:40.
20.	Ramirez J,Kieffer RF,Ball WC Jr. Bronchopulmonary lavage in man. Ann Intern Med,1965,63:819-828.
21.	Huizar I,Kavuru MS. Alveolar proteinosis syndrome:pathogenesis,diagnosis,andmanagement. Curr Opin Pulm Med,2009,15:491-498.
22.	Prakash UB,Barham SS,Carpenter HA,et al. Pulmonary alveolar phospholipoproteinosis:experience with 34 cases and review. Mayo Clin Proc,1987,62:499-518.
23.	Hasan N,Bagga S,Monteagudo J,et al. Extracorporeal membrane oxygenation to support whole-lung lavage in pulmonary alveolar proteinosis:salvage of the drowned lungs. J Bronchology Interv Pulmonol,2013,20:41-44.
24.	Seymour JF,Dunn AR,Vincent JM,et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med,1996,335:1924-1925.
25.	Kavuru MS,Sullivan EJ,Piccin R,et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,161:1143-1148.
26.	Seymour JF,Presneill JJ,Schoch OD,et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med,2001,163:524-531.
27.	Venkateshiah SB,Yan TD,Bonfield TL,et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest,2006,130:227-237.
28.	Reed JA,Ikegami M,Cianciolo ER,et al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol,1999,276:L556-563.
29.	Tazawa R,Hamano E,Arai T,et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2005,171:1142-1149.
30.	Wylam ME,Ten R,Prakash UB,et al. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J,2006,27:585-593.
31.	Tazawa R,Trapnell BC,Inoue Y,et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2010,181:1345-1354.
32.	Papiris SA,Tsirigotis P,Kolilekas L,et al. Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis:effectiveness,safety,and lowest effective dose. Clin Drug Investig,2014,34:553-564.
33.	Borie R,Debray M,Laine C,et al. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J,2009,33:1503-1506.
34.	Amital A,Dux S,Shitrit D, et al. Therapeutic effectiveness of rituximab in a patient with unresponsive autoimmune pulmonary alveolar proteinosis. Thorax,2010,65:1025-1026.
35.	Malur A,Kavuru MS,Marshall I,et al. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis. Respir Res,2012,13:46.
36.	Bonfield TL,Kavuru MS,Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol,2002,105:342-350.
37.	Tagawa T,Yamasaki N,Tsuchiya T,et al. Living-donor lobar lung transplantation for pulmonary alveolar proteinosis in an adult:report of a case. Surg Today,2011,41:1142-1144.
38.	Albores J,Seki A,Fishbein MC,et al. A rare occurrence of pulmonary alveolar proteinosis after lung transplantation. Semin Respir Crit Care Med,2013,34:431-438.
39.	Huddleston CB,Bloch JB,Sweet SC,et al. Lung transplantation in children. Ann Surg,2002,236:270-276.
40.	Khan A,Agarwal R. Pulmonary alveolar proteinosis.Respir Care,2011,56:1016-1028.
41.	白久武,李惠萍,史景云,等.胸部HRCT檢查在肺泡蛋白沉積癥分級診斷中應用的研究.中國實用內科雜志,2012,32:277-281.
42.	Yamamoto H,Yamaguchi E,Agata H,et al. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Pediatr Pulmonol,2008,43:828-830.

1. ?Rosen SG,Castleman B,Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med,1958,58:1123-1142.
2. Patel SM,Sekiguchi H,Reynolds JP. Pulmonary alveolar proteinosis. Can Respir J,2012,19:243-245.
3. Shah PL,Hansell D,Lawson PR,et al. Pulmonary alveolar proteinosis:clinical aspects and current concepts on pathogenesis. Thorax,2000,55:67-77.
4. Carey B,Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol,2010,135:223-235.
5. Khan A,Agarwal R,Aggarwal AN. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis:a meta-analysis of observational studies. Chest,2012,141:1273-1283.
6. Kavuru MS,Malur A,Marshall I,et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J,2011,38:1361-1367.
7. Luisetti M,Rodi G,Perotti C,et al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J,2009,33:1220-1222.
8. Verhasselt-Crinquette M,Franquet-Ansart H,Rakza T,et al. Congenital pulmonary alveolar proteinosis related to a surfactant protein B deficiency:report of two cases. Ann Pathol,2009,29:481-484.
9. Griese M,Ripper J,Sibbersen A,et al. Long-term follow-up and treatment of congenital alveolar proteinosis. BMC Pediatr,2011,11:72.
10. Dranoff G,Crawford AD,Sadelain M,et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science,1994,264:713-716.
11. Stanley E,Lieschke GJ,Grail D,et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA,1994,91:5592-5596.
12. Shibata Y,Berclaz PY,Chroneos ZC,et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity,2001,15:557-567.
13. Sakagami T,Uchida K,Suzuki T,et al. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med,2009,361:2679-2681.
14. Uchida K,Nakata K,Trapnell BC,et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colonystimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood,2004,103:1089-1098.
15. Sakagami T,Beck D,Uchida K,et al. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med,2010,182:49-61.
16. Ben-Dov I,Segel MJ. Autoimmune pulmonary alveolar proteinosis:clinical course and diagnostic criteria. Autoimmun Rev,2014,13:513-517.
17. Inoue Y,Trapnell BC,Tazawa R,et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med,2008,177:752-762.
18. Bonella F,Bauer PC,Griese M,et al. Pulmonary alveolar proteinosis:new insights from a single-center cohort of 70 patients. Respir Med,2011,105:1908-1916.
19. Campo I,Mariani F,Rodi G,et al. Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis,2013,8:40.
20. Ramirez J,Kieffer RF,Ball WC Jr. Bronchopulmonary lavage in man. Ann Intern Med,1965,63:819-828.
21. Huizar I,Kavuru MS. Alveolar proteinosis syndrome:pathogenesis,diagnosis,andmanagement. Curr Opin Pulm Med,2009,15:491-498.
22. Prakash UB,Barham SS,Carpenter HA,et al. Pulmonary alveolar phospholipoproteinosis:experience with 34 cases and review. Mayo Clin Proc,1987,62:499-518.
23. Hasan N,Bagga S,Monteagudo J,et al. Extracorporeal membrane oxygenation to support whole-lung lavage in pulmonary alveolar proteinosis:salvage of the drowned lungs. J Bronchology Interv Pulmonol,2013,20:41-44.
24. Seymour JF,Dunn AR,Vincent JM,et al. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med,1996,335:1924-1925.
25. Kavuru MS,Sullivan EJ,Piccin R,et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,161:1143-1148.
26. Seymour JF,Presneill JJ,Schoch OD,et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med,2001,163:524-531.
27. Venkateshiah SB,Yan TD,Bonfield TL,et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest,2006,130:227-237.
28. Reed JA,Ikegami M,Cianciolo ER,et al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol,1999,276:L556-563.
29. Tazawa R,Hamano E,Arai T,et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2005,171:1142-1149.
30. Wylam ME,Ten R,Prakash UB,et al. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J,2006,27:585-593.
31. Tazawa R,Trapnell BC,Inoue Y,et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2010,181:1345-1354.
32. Papiris SA,Tsirigotis P,Kolilekas L,et al. Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis:effectiveness,safety,and lowest effective dose. Clin Drug Investig,2014,34:553-564.
33. Borie R,Debray M,Laine C,et al. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J,2009,33:1503-1506.
34. Amital A,Dux S,Shitrit D, et al. Therapeutic effectiveness of rituximab in a patient with unresponsive autoimmune pulmonary alveolar proteinosis. Thorax,2010,65:1025-1026.
35. Malur A,Kavuru MS,Marshall I,et al. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis. Respir Res,2012,13:46.
36. Bonfield TL,Kavuru MS,Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol,2002,105:342-350.
37. Tagawa T,Yamasaki N,Tsuchiya T,et al. Living-donor lobar lung transplantation for pulmonary alveolar proteinosis in an adult:report of a case. Surg Today,2011,41:1142-1144.
38. Albores J,Seki A,Fishbein MC,et al. A rare occurrence of pulmonary alveolar proteinosis after lung transplantation. Semin Respir Crit Care Med,2013,34:431-438.
39. Huddleston CB,Bloch JB,Sweet SC,et al. Lung transplantation in children. Ann Surg,2002,236:270-276.
40. Khan A,Agarwal R. Pulmonary alveolar proteinosis.Respir Care,2011,56:1016-1028.
41. 白久武,李惠萍,史景云,等.胸部HRCT檢查在肺泡蛋白沉積癥分級診斷中應用的研究.中國實用內科雜志,2012,32:277-281.
42. Yamamoto H,Yamaguchi E,Agata H,et al. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Pediatr Pulmonol,2008,43:828-830.

Previous Article
去腎交感神經術治療頑固性高血壓合并阻塞性睡眠呼吸暫停的研究進展

Chinese Journal of Respiratory and Critical Care Medicine

特發性肺泡蛋白沉積癥治療進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content